READ. SCROLL. LISTEN.

Unbiased headlines. Facts, not spin.

Every story is an unbiased news briefing written from 110+ sources across the spectrum — sources linked so you can verify it yourself.

← Back to headlines

CDC Data: 40 Million American Adults With Arthritis Report Joint Pain, No Progress Since 2019

CDC Data: 40 Million American Adults With Arthritis Report Joint Pain, No Progress Since 2019
New federal survey data show 58.5% of U.S. adults with arthritis report moderate to severe joint pain in 2023, unchanged from 2019 and nowhere close to the government's own 2030 target. The CDC's own researchers say the fix isn't more pills, it's getting people into physical therapy and exercise programs that already exist and mostly go unused.

The government has a health goal it set for itself years ago. It is failing to meet it, and its own data proves it.

A CDC-led analysis of the 2023 National Health Interview Survey (NHIS) found that 58.5% of U.S. adults with arthritis reported moderate to severe joint pain, according to research published in Arthritis Care & Research by a team led by Elizabeth Fallon, PhD, DrPH, of the CDC in Atlanta. Age-adjusted, that figure comes to 58.2%.

Break it down further. Among adults diagnosed with arthritis, 26.1% reported severe joint pain. Another 32.4% reported moderate pain. Add in everyone reporting even mild joint pain, and the total hits 75.8% of arthritis patients, which the researchers translate to roughly 40 million American adults.

In 2019, the age-adjusted rate for moderate-to-severe joint pain was 56.8%. Four years later, it's 58.2%. This is flat, maybe worse. The Healthy People 2030 initiative, a federal effort setting national health targets, wants that number down to 52.4%. The 2023 data show the country isn't just falling short, it's moving the wrong direction.

Why This Isn't Just Bad Luck

The researchers don't point to a mystery disease or an unavoidable demographic shift. They point to a treatment gap that's been documented for years and apparently still hasn't been closed.

The CDC's own Clinical Practice Guideline for Prescribing Opioids for Pain recommends multidisciplinary care that leans on non-opioid, non-drug therapies first. The American College of Rheumatology backs this up, recommending physical therapy, occupational therapy, exercise, and weight management for arthritis patients.

None of that is controversial. It's the standard of care.

The problem, according to Fallon and her colleagues, is that "referrals to physical therapy are underutilized, many adults with arthritis are either inactive or do not meet physical activity guidelines, and too few have received health care provider advice for physical activity or exercise to manage their arthritis." Doctors aren't consistently telling patients to move, and patients aren't consistently getting connected to the therapy programs that actually help.

The Fix Already Exists

The study points to something that already exists: 22 arthritis-related interventions developed by the Osteoarthritis Action Alliance.

These include physical activity programs and self-management education programs that the researchers say are "proven to improve arthritis symptoms or quality of life among adults with arthritis." They can be run out of health clinics, veteran-serving organizations, senior centers, YMCAs, or delivered remotely, often at low or no cost.

So the tools are on the shelf. They're just not reaching the 40 million adults who need them. This is not a funding failure or a science failure. It's a delivery failure, and it's happening inside a health system that spends more per capita on care than almost any country on earth.

A Fair Caveat on the Numbers

NHIS participants are asked if a doctor or other healthcare professional ever told them they have "arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia." Follow-up questions then narrow in on joint pain, specifically excluding neck or back pain, and ask patients to self-rate its severity.

This is self-reported data with no objective clinical validation behind it, and it opens the door to recall bias. Someone who had a bad flare-up in the weeks before the survey might report differently than someone who didn't. It's a fair point to raise before treating 58.5% as gospel, and it doesn't erase the trend, but it should temper how precisely anyone cites the number.

Still, the survey uses roughly 30,000 respondents in each cycle, run consistently by the same federal agency across years, which is why the 2019-to-2023 comparison holds up as a real trend rather than statistical noise.

What Happens Next

Nothing in the study announces a new CDC program, a funding bump, or a policy change. It's a data release, and a fairly blunt one, from the same federal agency that set the 52.4% target the country is now missing by nearly six percentage points.

Whether insurers, primary care doctors, and health systems start referring patients to the available interventions at scale, or whether this data point sits in a journal until the next NHIS cycle rolls around in a few years, remains to be seen. The interventions the researchers cite through the Osteoarthritis Action Alliance are already available in community settings across the country.

Sources used for this briefing

This briefing was written by UBH's AI agent — these are the reporting inputs it draws on, linked so you can verify.

center
MedPage TodayArthritis Pain Management Falls Short in U.S., CDC Study Suggests